Literature DB >> 15784691

Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis.

Kristina Trenz1, Petra Schütz, Günter Speit.   

Abstract

Lymphoblastoid cell lines (LCL) with a heterozygous mutation in the breast cancer susceptibility gene BRCA1 have been repeatedly used to elucidate the biological consequences of such a mutation with respect to radiation sensitivity and DNA repair deficiency. Our previous results indicated that LCL with a BRCA1 mutation do not generally show the same chromosomal mutagen sensitivity in the micronucleus test as lymphocytes with the same BRCA1 mutation. To further study the radiosensitivity of LCL with a BRCA1 mutation, we now performed comparative investigations with the alkaline (pH 13) and the neutral (pH 8.3) comet assay and pulsed field gel electrophoresis (PFGE). These tests are commonly used to determine the repair capacity for DNA double strand breaks (DNA-DSB). Six LCL (three established from women with a heterozygous BRCA1 mutation and three from healthy controls) were investigated. Induction (2 and 5 Gy) of gamma-ray-induced DNA damage and its repair (during 60 min after irradiation) was measured with the alkaline and neutral comet assay. Comparative experiments were performed with PFGE determining the induction of DNA-DSB by 10-50 Gy gamma-irradiation and their repair during 6 h. There was no significant difference between LCL with and without BRCA1 mutation in any of these experiments. Therefore, using these methods, no indication for a delayed repair of DNA-DSB in LCL with a BRCA1 mutation was found. However, these results do not generally exclude DNA-DSB repair deficiency in these cell lines because the methods applied have limited sensitivity and only measure the speed but not the fidelity of the repair process.

Entities:  

Mesh:

Year:  2005        PMID: 15784691     DOI: 10.1093/mutage/gei018

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  4 in total

1.  Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes.

Authors:  Jean J Latimer; Wendy S Rubinstein; Jennifer M Johnson; Amal Kanbour-Shakir; Victor G Vogel; Stephen G Grant
Journal:  BMC Med Genet       Date:  2005-06-14       Impact factor: 2.103

2.  DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers.

Authors:  J Kotsopoulos; Z Chen; K A Vallis; A Poll; P Ainsworth; S A Narod
Journal:  Br J Cancer       Date:  2007-01-15       Impact factor: 7.640

3.  ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition.

Authors:  Scott J Pearson; Tapasree Roy Sarkar; Cole M McQueen; Jessica Elswood; Emily E Schmitt; Steven W Wall; Kelly C Scribner; Garhett Wyatt; Rola Barhoumi; Fariba Behbod; Monique Rijnkels; Weston W Porter
Journal:  Oncogene       Date:  2018-12-10       Impact factor: 9.867

Review 4.  Lymphoblastoid Cell lines: a Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair.

Authors:  Tabish Hussain; Rita Mulherkar
Journal:  Int J Mol Cell Med       Date:  2012
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.